Abdul Mannan: Type 2N VWD Can Wear Haemophilia A’s Lab Coat
Abdul Mannan, Consultant Haematologist, Director Haemophilia Centre, Haematology Lab Lead at Betsi Cadwaladr University Health Board, Founder of Blood Doctor, shared a post on LinkedIn:
“Type 2N von Willebrand disease can wear haemophilia A’s lab coat.
Low factor VIII. Similar bleeding. Different gene. Different family story.
Here is the trap:
- VWF normally binds and protects factor VIII.
- In type 2N, VWF is present, but its FVIII-binding function is defective. FVIII is cleared too quickly.
- VWF antigen and activity may be normal or reduced. FVIII is low out of proportion to VWF.
- The FVIII:C and VWF:Ag ratio is often below 0.6–0.7. But this is a clue, not a universal diagnostic cut-off.
- Confirm with a VWF:FVIIIB assay interpreted against VWF:Ag and the local laboratory range, and/or targeted VWF genetic testing.
- A VWF variant supports type 2N, which is usually autosomal recessive. An F8 variant points towards haemophilia A, which is X-linked.
Why does naming it matter?
Because treatment planning, family counselling and testing relatives all change. DDAVP response cannot be assumed either. In 123 genetically confirmed patients, Daniel and colleagues found genotype-linked variation in FVIII levels, bleeding and DDAVP response.
So when FVIII is low, ask one more question:
Is factor VIII missing, or has its carrier stopped holding on?
Would your laboratory pathway catch this before someone is labelled as having mild haemophilia A?”

More posts from Abdul Mannan on Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health